There are now several monoclonal antibodies, identical copies of a therapeutic antibody produced in large numbers, that are authorized for the treatment of COVID-19. But in the ongoing effort to beat this terrible pandemic, theres plenty of room for continued improvements in treating infections with SARS-CoV-2, the virus that causes... Read More . . . |